These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 397029)

  • 1. [Controlled evaluation of a new synthetic spasmolytic (DA 3177) in/pathology of the digestive system].
    Battocchio F; Negri L; Tacchettti G
    Clin Ter; 1979 Jun; 89(6):601-10. PubMed ID: 397029
    [No Abstract]   [Full Text] [Related]  

  • 2. [DA 3177 a new synthetic spasmolytic agent in the management of spastic-dyskinetic conditions of the digestive tract. Double-blind controlled clinical trial].
    Bonzi G; Reguzzoni G; Rocca F; Negri L
    Clin Ter; 1979 Apr; 89(2):187-96. PubMed ID: 385213
    [No Abstract]   [Full Text] [Related]  

  • 3. Are anticholinergics of use in the irritable colon syndrome?
    Ivey KJ
    Gastroenterology; 1975 May; 68(5 Pt 1):1300-7. PubMed ID: 1092588
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of a new synthetic spasmolytic (DA 3177) in emergency medicine].
    Del Fabbro L; Di Bartolomeo C; Grassi L; Lestuzzi A; Perraro F; Tosolini G
    Clin Ter; 1977 Dec; 83(6):609-23. PubMed ID: 343975
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new long-lasting anticholinergic drug in gastroduodenal pathology].
    Pergola F
    Med Chir Dig; 1977; 6(2):105-7. PubMed ID: 875504
    [No Abstract]   [Full Text] [Related]  

  • 6. Fenoverine: a two-step, double-blind and open clinical assessments of its smooth muscle synchronizing effects.
    Bader F
    Pharmatherapeutica; 1986; 4(7):422-8. PubMed ID: 3515369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of treatments with the phytopharmaceuticals bilicura and spasmobilicura in disorders of the liver-bile-digestive system].
    Gracza L; Gracza E
    Fortschr Med; 1977 Dec; 95(47-48):2829-31. PubMed ID: 590909
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and instrumental evaluation by multiple colonic manometry of tiropramide, trimebutine and octylonium bromide in irritable colon. II. Repeated oral administration].
    Galeone M; Benazzi E; Bossi M; Moise G; Riva A; Stock F
    Pharmatherapeutica; 1986; 4(8):496-509. PubMed ID: 3714757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic trial with a new anti-gastrin agent combined with a spasmolytic].
    Malafaia O
    Rev Bras Med; 1972 Mar; 29(3):148-50. PubMed ID: 5033158
    [No Abstract]   [Full Text] [Related]  

  • 10. Fenoverine: smooth muscle synchronizer for the management of gastro-intestinal conditions. II. A trimebutine-controlled, double-blind, crossover clinical evaluation.
    Camarri E
    Curr Med Res Opin; 1986; 10(1):52-7. PubMed ID: 3516580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimebutine, a new antispasmodic in the treatment of dyspepsia.
    Walters JM; Crean P; McCarthy CF
    Ir Med J; 1980 Oct; 73(10):380-1. PubMed ID: 7429788
    [No Abstract]   [Full Text] [Related]  

  • 12. [Trial in abdominal surgery of a new molecule, trimebutine, in resumption of postoperative transit].
    Francillon J; Philippe MP
    Lyon Med; 1971 Feb; 225(4):363-5. PubMed ID: 5088602
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experimentation with pentanobornamide, a new synthetic spasmolytic].
    Miracco A; Peluso C
    Clin Ter; 1970 Mar; 52(6):557-63. PubMed ID: 4916457
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the spasmolytic efficacy of prifinium bromide in gastrointestinal pathology].
    Garcia Hidalgo E; Fernández Navarro MD; Arias Vallejo E
    Rev Esp Enferm Apar Dig; 1972 May; 37(3):397-406. PubMed ID: 5031449
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic effects of a new antispastic and anxiolytic preparation on various diseases of the digestive tract].
    Surrenti C
    Clin Ter; 1970 May; 53(3):235-46. PubMed ID: 5456481
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical trial of a new drug with gastrointestinal action: bromopride].
    Carli G; Petracca E; Ramazzina E
    Clin Ter; 1981 Oct; 99(2):173-86. PubMed ID: 7032832
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of a new gastroenterotrophic, spasmolytic and antacid combination (Gefarmil compositum)].
    Rovera R; Furlotti MG
    Minerva Gastroenterol; 1970; 16(4):191-8. PubMed ID: 4930898
    [No Abstract]   [Full Text] [Related]  

  • 18. Double blind trial of trimebutine in the irritable bowel syndrome.
    Fielding JF
    Ir Med J; 1980 Oct; 73(10):377-9. PubMed ID: 7000730
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of sulpiride in organic and functional digestive pathology].
    Geoffroy H; Bajolet S; Coudoux P; Brunois JP; Chardon P; Behar C; Dalle M; Deroche B
    Sem Hop; 1970 Jun; 46(29):Suppl:23-9. PubMed ID: 4316824
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of pirenzepine in peptic ulcer and in non ulcerous gastroduodenal diseases. A multicentre controlled clinical trial.
    Giorgi-Conciato M; Daniotti S; Ferrari PA; Gaetani M; Petrin G; Sala P; Valentini P
    Scand J Gastroenterol Suppl; 1982; 81():1-41. PubMed ID: 6221398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.